Orient, NanoCarrier sign deal for Nanoplatin trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2012
Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreeme...Read more
Novogen's ovarian cancer drug set for trials in H1 2016
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 May, 2016
US-Australian drug discovery company, Novogen Limited has provided an update on progress regarding the development of Ca...Read more
Japanese scientist inch closer to Toxoplasma vaccine discovery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2015
Tokyo: Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunod...Read more
Australia's Gordagen forays into Japan with Matsumoto's support
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2016
Tokyo: Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, has...Read more
Takeda gets NDA approval for VAXEM Hib vaccine in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2016
Takeda Pharmaceutical Company Limited has announced that the Japanese Ministry of Health, Labour and Welfare has approve...Read more
Aspirin use increases risk of age-related eye disease
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013
Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WM...Read more
Systems Toxicology Computational Challenge explores toxicant prediction
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2016
Singapore: The Systems Toxicology Computational Challenge run under the sbv IMPROVER umbrella, a crowdsourcing initiativ...Read more
University of Dundee, Ono Pharma to collaborate on drug research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2016
A Japanese delegation will initiate a partnership with University of Dundee seeking to develop new treatments for inflam...Read more
FDA approves Eli Lilly's combination drug for metastatic colorectal cancer
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 27 Apr, 2015
Singapore: US Food and Drug Administration has approved Eli Lilly's ramucirumab (Cyramza) for use in combination with Fo...Read more
Scientists use tiniest human protein to heal heart
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2013
Singapore: Scientists at A*Star's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IM...Read more
Drug Discovery | Analysis | By BioSpectrum Bureau | 0 Comment | 08 Apr, 2016
Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to...Read more
BMS uses Santaris platform for drug discovery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Apr, 2013
Singapore: Santaris Pharma, a privately held biopharmaceutical company focused on developing medicines targeted to disea...Read more
Mitsubishi Tanabe to manufacture diabetes drug Tenelia
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2012
Singapore: Japanese company Mitsubishi Tanabe has received approval to manufacture and market the selective DPP-4 inhibi...Read more
Wockhardt increases investment in R&D
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Sep, 2015
Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plan...Read more
Sosei' subsidiary Heptares records positive outcome of Schizophrenia drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Feb, 2016
Sosei Group Corporation has reported that Heptares Therapeutics, the wholly-owned subsidiary of Japan's Sosei Group Corp...Read more
FDA warns against Mitshubi Tanabe's type 2 diabetes drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2015
Singapore: US Food and Drug Administration (FDA) has warned against type 2 diabetes medicine, canagliflozin (Invokana, I...Read more
Aussie anesthetic firm gets patent from 7 nations
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...Read more
Australia's TransBio, DendroCyte to develop antibody for transplant rejection
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Sep, 2015
Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and ...Read more